Clorox’s 21% YTD Slide and 318th-Ranked Trading Volume Highlight Struggles vs. S&P 500

Generated by AI AgentAinvest Volume Radar
Thursday, Sep 4, 2025 7:24 pm ET1min read
Aime RobotAime Summary

- Clorox’s stock fell 21.21% YTD, closing at $124.31 with 318th-ranked $0.34B trading volume on Sept 4, 2025.

- Analysts cited cost pressures and earnings volatility, with Wells Fargo lowering its price target to $130 amid global economic uncertainties and competition from Reckitt and Procter & Gamble.

- Despite cost management and a $1.24/share dividend hike, near-term risks include inflation and shifting consumer demand in the household goods sector.

On September 4, 2025,

(CLX) closed at $124.31, down 0.26% with a trading volume of $0.34 billion, ranking 318th in market activity. The stock has declined 21.21% year-to-date, underperforming the S&P 500’s 10.55% gain. Analyst Herb Greenberg highlighted concerns over rising costs and earnings volatility, while reduced its price target to $130 from $138, reflecting cautious sentiment amid global economic uncertainties.

CLX faced pressure from May’s sales guidance cut linked to tariffs and macroeconomic headwinds, despite limited exposure to China and Mexico. Recent product innovations, such as CloroxPro’s Screen+ sanitizing wipes for electronics and a new partnership with Vizient, aim to bolster market share in the disinfectant sector. However, broader industry competition from peers like Reckitt Benckiser and

remains a challenge.

Backtest data shows CLX’s 12-month return at -21.45%, lagging the S&P 500’s 17.79% performance. The company’s focus on cost management and dividend sustainability—raising its payout to $1.24 per share—may provide some support, but near-term risks include inflationary pressures and shifting consumer demand in the household goods sector.

Comments



Add a public comment...
No comments

No comments yet